SLC35E4 Antikörper (AA 1-350)
-
- Target Alle SLC35E4 Antikörper anzeigen
- SLC35E4 (Solute Carrier Family 35, Member E4 (SLC35E4))
- Bindungsspezifität
- AA 1-350
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser SLC35E4 Antikörper ist unkonjugiert
-
Applikation
- ELISA, Western Blotting (WB), Flow Cytometry (FACS)
- Verwendungszweck
- Anti-SLC35E4 Antibody Picoband®
- Kreuzreaktivität (Details)
- No cross-reactivity with other proteins.
- Produktmerkmale
- Anti-SLC35E4 Antibody Picoband® (ABIN7599299). Tested in ELISA, Flow Cytometry, WB applications. This antibody reacts with Human. The brand Picoband indicates this is a premium antibody that guarantees superior quality, high affinity, and strong signals with minimal background in Western blot applications. Only our best-performing antibodies are designated as Picoband, ensuring unmatched performance.
- Aufreinigung
- Immunogen affinity purified.
- Immunogen
- E.coli-derived human SLC35E4 recombinant protein (Position: M1-L350).
- Isotyp
- IgG
-
-
- Applikationshinweise
-
Western blot, 0.25-0.5 μg/mL, Human
Flow Cytometry (Fixed), 1-3 μg/1x106 cells, Human
ELISA, 0.1-0.5 μg/mL, -
1. Collins, J. E., Wright, C. L., Edwards, C. A., Davis, M. P., Grinham, J. A., Cole, C. G., ... & Dunham, I. (2004). A genome annotation-driven approach to cloning the human ORFeome. Genome biology, 5(10), 1-11. 2. Wu, S. F., Xia, L., Shi, X. D., Dai, Y. J., Zhang, W. N., Zhao, J. M., ... & Chen, S. (2020). RIG-I regulates myeloid differentiation by promoting TRIM25-mediated ISGylation. Proceedings of the National Academy of Sciences, 117(25), 14395-14404. 3. Luck, K., Kim, D. K., Lambourne, L., Spirohn, K., Begg, B. E., Bian, W., ... & Calderwood, M. A. (2020). A reference map of the human binary protein interactome. Nature, 580(7803), 402-408. - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Adding 0.2 mL of distilled water will yield a concentration of 500 μg/mL.
- Konzentration
- 500 μg/mL
- Buffer
- Each vial contains 4 mg Trehalose, 0.9 mg NaCl, 0.2 mg Na2HPO4.
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
-
At -20°C for one year from date of receipt. After reconstitution, at 4°C for one month.
It can also be aliquotted and stored frozen at -20°C for six months. Avoid repeated freezing and thawing.
-
- Target
- SLC35E4 (Solute Carrier Family 35, Member E4 (SLC35E4))
- Andere Bezeichnung
- SLC35E4 (SLC35E4 Produkte)
- Hintergrund
-
Synonyms: Placenta-specific protein 9, PLAC9
Tissue Specificity: Detected in liver, skeletal muscle, kidney, pancreas, spleen, thyroid, testis, ovary, small intestine and colon.
Background: Predicted to enable antiporter activity. Predicted to be involved in transmembrane transport. Predicted to be integral component of membrane. Predicted to be active in Golgi apparatus.
- Molekulargewicht
- 40 kDa
- Gen-ID
- 339665
-